Ironwood Pharmaceuticals | IRWD - Loan Capital



Ironwood Pharmaceuticals reported $583.99M in Loan Capital for its fiscal quarter ending in December of 2024.


Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Agios Pharmaceuticals USD 0 0 Mar/2025
Almirall EUR 365.88M 24.38M Jun/2025
Alnylam Pharmaceuticals USD 1.03B 956K Jun/2025
Amarin USD 0 0 Mar/2025
Ardelyx USD 229.21M 78.36M Jun/2025
Astellas Pharma JPY 558.08B 6.82B Jun/2025
AstraZeneca USD 25.99B 1.9B Jun/2025
Charles River Laboratories USD 2.33B 178.38M Jun/2025
Exact Sciences USD 2.32B 9.48M Jun/2025
Halozyme Therapeutics USD 1.51B 1.65M Jun/2025
Incyte USD 31.76M 883K Jun/2025
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
MacroGenics USD 70.26M 70.26M Jun/2025
Moderna USD 32M 3M Jun/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Pacira USD 378.1M 3.2M Jun/2025
PTC Therapeutics USD 2.13B 1.85B Jun/2025
Sarepta Therapeutics USD 1.14B 1.17M Jun/2025
Takeda JPY 4.13T 168.47B Jun/2025
Ultragenyx Pharmaceutical USD 782.75M 782.75M Jun/2025